# Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

> **NCT02933021** · — · UNKNOWN · sponsor: **RxCelerate Ltd** · enrollment: 664 (actual)

## Conditions studied

- Monoclonal Gammopathy of Unknown Significance

## Interventions

- **OTHER:** Blood sample taken
- **OTHER:** Answering a lifestyle questionnaire
- **OTHER:** Follow-up phone call from researcher (two years after first visit)

## Key facts

- **NCT ID:** NCT02933021
- **Lead sponsor:** RxCelerate Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2019-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 664 (ACTUAL)
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933021, "Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02933021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*